Short answer · Medically reviewed summary · Last updated: 2026-04-07
Camurati-Engelmann disease is a rare genetic disorder characterized by the thickening of the shafts of long bones, and it is most commonly referred to by its eponyms or as progressive diaphyseal dysplasia. Because it has been described under various names historically, patients may encounter terms such as Engelmann disease or osteopathia hyperostotica scleroticans multiplex infantilis in older medical literature or international records. Why does Camurati-Engelmann disease have so many names? The nomenclature for Camurati-Engelmann disease reflects its history of discovery by multiple researchers in the early 20th century.
Camurati-Engelmann disease synonyms
Other names for Camurati-Engelmann disease: synonyms, acronyms and related terms used by doctors and patients.
Camurati-Engelmann disease is a rare genetic disorder characterized by the thickening of the shafts of long bones, and it is most commonly referred to by its eponyms or as progressive diaphyseal dysplasia. Because it has been described under various names historically, patients may encounter terms such as Engelmann disease or osteopathia hyperostotica scleroticans multiplex infantilis in older medical literature or international records.
Why does Camurati-Engelmann disease have so many names?
The nomenclature for Camurati-Engelmann disease reflects its history of discovery by multiple researchers in the early 20th century. Mario Camurati described the condition in 1922, and Guido Engelmann provided a detailed report in 1929. Consequently, the condition was frequently referred to as Camurati-Engelmann syndrome or Engelmann’s disease in various European journals. As genetic research advanced and the underlying cause—mutations in the TGFB1 gene—was identified, the medical community moved toward more descriptive, standardized terminology. Despite this, older synonyms persist in historical case reports and legacy electronic health records, which can sometimes lead to confusion for patients seeking information.
What are the primary synonyms and abbreviations used today?
When searching for medical literature or clinical trial data, you will likely encounter several terms for Camurati-Engelmann disease. Using the correct terminology can help you navigate databases like PubMed or Orphanet more effectively. The following list includes the most common synonyms and classifications:
- Progressive diaphyseal dysplasia (PDD): The most widely accepted descriptive clinical term.
- Engelmann disease: An older eponym still frequently used in clinical shorthand.
- Camurati-Engelmann syndrome: A common variant of the official name.
- Osteopathia hyperostotica scleroticans multiplex infantilis: A historical, highly descriptive term occasionally found in older international literature.
- ICD-10/11 classification: Often coded under rare bone diseases or genetic osteochondrodysplasias.
Which terminology is preferred by medical professionals?
In modern clinical practice, Camurati-Engelmann disease or progressive diaphyseal dysplasia (PDD) are the preferred terms. Medical professionals utilize these names because they clearly identify the condition's pathology: a progressive thickening (hyperostosis) of the diaphysis (the shaft) of the long bones. While 107 members of the DiseaseMaps.org community use the name Camurati-Engelmann disease to connect with one another, researchers often use PDD in academic papers to emphasize the genetic etiology linked to the Transforming Growth Factor-Beta 1 (TGFB1) gene.
How are these names standardized in global databases?
Major medical institutions have worked to unify these terms to ensure consistent patient care. In the OMIM (Online Mendelian Inheritance in Man) database, the condition is cataloged as Camurati-Engelmann disease (OMIM #131300). Orphanet, the reference portal for rare diseases, also uses this as the primary entry point while listing synonyms to ensure that physicians and patients worldwide can find the same diagnostic information regardless of the specific term used in their local medical tradition.
Next steps
- Consult with a geneticist to confirm your diagnosis through TGFB1 molecular testing.
- Connect with the 107 peers in the DiseaseMaps.org community to share experiences and coping strategies.
- Request that your primary care physician uses the term "Progressive Diaphyseal Dysplasia" alongside Camurati-Engelmann disease in your medical records for clarity.
- Visit the NIH GARD website to stay updated on current clinical research and potential treatment trials.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- Orphanet: Rare Disease Database (ORPHA:269)
- NIH Genetic and Rare Diseases Information Center (GARD)
- OMIM (Online Mendelian Inheritance in Man): Entry #131300
- PubMed/NCBI: Literature on TGFB1-related bone dysplasias
